565 results on '"Di Nicola, Marco"'
Search Results
2. Physical and cognitive correlates, inflammatory levels, and treatment response in post-COVID-19 first-onset vs. recurrent depressive episodes
3. Limited Access to Emotion Regulation Strategies Mediates the Association Between Positive Urgency and Sustained Binge Drinking in Patients with Alcohol Use Disorder
4. Are visual analogue scales valid instruments to measure psychological pain in psychiatric patients?
5. Childhood sexual abuse and suicide attempts in patients with substance use disorders: The mediating role of emotion dysregulation
6. The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data
7. Predicting outcome with Intranasal Esketamine treatment: A machine-learning, three-month study in Treatment-Resistant Depression (ESK-LEARNING)
8. Predictors of polysubstance use in patients with severe alcohol use disorder: the role of reward craving
9. Substance use disorders in adults with attention-deficit/hyperactivity disorder: The role of affective temperament
10. Effect of affective temperament on illness characteristics of subjects with bipolar disorder and major depressive disorder
11. Case report: complete long-lasting response to multimodal third line treatment with neurosurgical resection, carmustine wafer implantation and dabrafenib plus trametinib in a BRAFV600E mutated high-grade glioma
12. Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation
13. 3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18F-FDG PET/CT Case Report
14. Use of social network as a coping strategy for depression among young people during the COVID-19 lockdown: findings from the COMET collaborative study
15. Factors associated with lifetime suicide attempts in bipolar disorder: results from an Italian nationwide study
16. Anomalous self-experience, body image disturbance, and eating disorder symptomatology in first-onset anorexia nervosa
17. Profiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdown.
18. Corrigendum: Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report
19. Investigating the Effectiveness of Brexpiprazole in Schizophrenic Patients with Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Study
20. The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data
21. Case report: complete longlasting response to multimodal third line treatment with neurosurgical resection, carmustine wafer implantation and dabrafenib plus trametinib in a BRAFV600E mutated highgrade glioma.
22. 3-Methoxy-Phencyclidine Induced Psychotic Disorder: A Literature Review and an 18 F-FDG PET/CT Case Report.
23. Investigating the Effectiveness of Brexpiprazole in Subjects with Schizophrenia Spectrum Illness and Co-Occurring Substance Use Disorder: A Prospective, Multicentric, Real-World Study.
24. When Clozapine Fails: Augmentation Strategies in the Management of Clozapine-Resistant Schizophrenia
25. Mixed States in Patients with Substance and Behavioral Addictions
26. MDMA-Based Psychotherapy in Treatment-Resistant Post-Traumatic Stress Disorder (PTSD): A Brief Narrative Overview of Current Evidence
27. The Patient’s Perspective on the Effects of Intranasal Esketamine in Treatment-Resistant Depression
28. Sense of Agency and Its Disturbances: a Systematic Review Targeting the Intentional Binding Effect in Neuropsychiatric Disorders
29. Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemo-radiotherapy: a case report
30. Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study
31. Psychiatric disorders and SLC6A4 gene variants: possible effects on alcohol dependence and alzheimer’s disease
32. Atypical Antipsychotics in Major Depressive Disorder
33. Temperament and character influence on depression treatment outcome
34. Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemoradiotherapy: a case report.
35. What Came First, Mania or Depression? Polarity at Onset in Bipolar I and II: Temperament and Clinical Course.
36. Sense of agency and its disturbances: A systematic review targeting the intentional binding effect in neuropsychiatric disorders.
37. MDMA-Based Psychotherapy in Treatment-Resistant Post-traumatic Stress Disorder (PTSD): A Brief Overview of Current Evidence
38. Childhood trauma and resilience in psoriatic patients: A preliminary report
39. Relationship between craving and plasma leptin concentrations in patients with cocaine addiction
40. Physical and cognitive correlates, inflammatory levels, and treatment response in post-COVID-19 first-onset vs. recurrent depressive episodes
41. Vortioxetine improves physical and cognitive symptoms in patients with post-COVID-19 major depressive episodes
42. Adherence to, and Persistence of, Antidepressant Therapy in Patients with Major Depressive Disorder: Results from a Population-based Study in Italy
43. S-Adenosyl-L-Methionine for Major Depressive Disorder
44. Neural correlates of cognitive control in gambling disorder: a systematic review of fMRI studies
45. Bevacizumab-Irinotecan combination therapy in recurrent low-grade glioma, previously treated with chemoradiotherapy: a case report.
46. Alcoholism in Bipolar Disorders: An Overview of Epidemiology, Common Pathogenetic Pathways, Course of Disease, and Implications for Treatment
47. List of Contributors
48. Pharmacological and Psychosocial Treatment of Adults With Gambling Disorder: A Meta-Review
49. When Clozapine Fails: Augmentation Strategies in the Management of Clozapine-Resistant Schizophrenia
50. Functional Movement Disorders during COVID-19: Psychological Distress, Affective Temperament and Emotional Dysregulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.